Back

LDL-C: The race to the bottom

2 September 2019 (19:20 - 19:35)
Organised by:
Congress Presentation Part of: Insights and innovation - Can we alter the course of atherosclerotic cardiovascular disease? Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Eugene Braunwald

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

5 More presentations in this session

Presentation thumbnail
Introduction and purpose
Doctor B. Berkowitz (New York, US)
Slides Video
Presentation thumbnail
RNA interference - Building oligonucleotides as therapeutics
Mr D. Corey (Dallas, US)
Slides Video
Presentation thumbnail
Cumulative exposure - Estimating the benefits of intervention
Professor B. Ference (Cambridge, GB)
Slides Video
Presentation thumbnail
With recent news - here's what's possible
Professor J. Kastelein (Amsterdam, NL)
Slides Video
Presentation thumbnail
Panel and audience questions and answers
Doctor B. Berkowitz (New York, US)
Slides Video

Access the full session

Session thumbnail
Insights and innovation - Can we alter the course of atherosclerotic cardiovascular disease?

The Event

Event poster

ESC Congress 2019

2 September 2019 19:20 CET
You may be interested in
thumbnail
Congress Presentation
Redrawing the map: why we must cross boundaries in lipid management
29 August 2025
thumbnail
Congress Presentation
LDL treatment-years: a new paradigm for cardiovascular risk reduction
1 September 2025
thumbnail
Congress Presentation
Q&A and meeting close
27 August 2023
thumbnail
Congress Presentation
Does early initiation of non-statin therapy, evolocumab with LDL-C <50mg/dL contribute to the reduction of hospital readmissions in patients with ACS?: a single center real world evidence from ELAINE
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources